These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1098 related articles for article (PubMed ID: 18978771)
21. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270 [TBL] [Abstract][Full Text] [Related]
22. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368 [TBL] [Abstract][Full Text] [Related]
23. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Hermann E; Alonso-Vega C; Berthe A; Truyens C; Flores A; Cordova M; Moretta L; Torrico F; Braud V; Carlier Y Pediatr Res; 2006 Jul; 60(1):38-43. PubMed ID: 16690951 [TBL] [Abstract][Full Text] [Related]
24. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection. Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004 [TBL] [Abstract][Full Text] [Related]
25. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion. Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Hughes T; Becknell B; Freud AG; McClory S; Briercheck E; Yu J; Mao C; Giovenzana C; Nuovo G; Wei L; Zhang X; Gavrilin MA; Wewers MD; Caligiuri MA Immunity; 2010 Jun; 32(6):803-14. PubMed ID: 20620944 [TBL] [Abstract][Full Text] [Related]
27. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
29. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499 [TBL] [Abstract][Full Text] [Related]
30. New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Wilk E; Kalippke K; Buyny S; Schmidt RE; Jacobs R Immunobiology; 2008; 213(3-4):271-83. PubMed ID: 18406373 [TBL] [Abstract][Full Text] [Related]
31. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Naume B; Johnsen AC; Espevik T; Sundan A Eur J Immunol; 1993 Aug; 23(8):1831-8. PubMed ID: 7688307 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Ciccia F; Accardo-Palumbo A; Alessandro R; Rizzo A; Principe S; Peralta S; Raiata F; Giardina A; De Leo G; Triolo G Arthritis Rheum; 2012 Jun; 64(6):1869-78. PubMed ID: 22213179 [TBL] [Abstract][Full Text] [Related]
33. STAT3 and its activators in intestinal defense and mucosal homeostasis. Hruz P; Dann SM; Eckmann L Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863 [TBL] [Abstract][Full Text] [Related]
34. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. Kuhara T; Yamauchi K; Tamura Y; Okamura H J Interferon Cytokine Res; 2006 Jul; 26(7):489-99. PubMed ID: 16800788 [TBL] [Abstract][Full Text] [Related]
35. HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets. Quaranta MG; Napolitano A; Sanchez M; Giordani L; Mattioli B; Viora M FASEB J; 2007 Aug; 21(10):2323-34. PubMed ID: 17431094 [TBL] [Abstract][Full Text] [Related]
36. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
37. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Hughes T; Becknell B; McClory S; Briercheck E; Freud AG; Zhang X; Mao H; Nuovo G; Yu J; Caligiuri MA Blood; 2009 Apr; 113(17):4008-10. PubMed ID: 19244159 [TBL] [Abstract][Full Text] [Related]
38. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells. Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891 [TBL] [Abstract][Full Text] [Related]
39. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Hughes T; Briercheck EL; Freud AG; Trotta R; McClory S; Scoville SD; Keller K; Deng Y; Cole J; Harrison N; Mao C; Zhang J; Benson DM; Yu J; Caligiuri MA Cell Rep; 2014 Jul; 8(1):150-62. PubMed ID: 24953655 [TBL] [Abstract][Full Text] [Related]
40. Effector and regulatory events during natural killer-dendritic cell interactions. Moretta L; Ferlazzo G; Bottino C; Vitale M; Pende D; Mingari MC; Moretta A Immunol Rev; 2006 Dec; 214():219-28. PubMed ID: 17100887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]